# GAGE12C

## Overview
GAGE12C is a gene that encodes the G antigen 12C protein, a member of the GAGE family of cancer-testis antigens. These proteins are typically expressed in a variety of tumors and are known for their restricted expression in normal tissues, primarily in the testis. The G antigen 12C protein is implicated in several cancer-related processes, including tumor progression, immune evasion, and resistance to apoptosis. It plays a significant role in enhancing chromatin dynamics, which aids in DNA repair and contributes to the resistance against radiation-induced cell death in cancer cells (Nin2023Biology). The expression of GAGE12C is associated with poor prognostic outcomes in multiple myeloma and is involved in the regulation of epithelial-to-mesenchymal transition (EMT) genes, which are crucial for cancer metastasis (Nin2023Biology; Moreaux2010A). These characteristics make GAGE12C a potential target for cancer therapy, particularly in high-risk patient groups.

## Function


## Clinical Significance
GAGE12C, a member of the GAGE family of cancer-testis antigens, is implicated in various cancer-related processes. Alterations in the expression of GAGE12C have been associated with tumor progression and immune evasion. In multiple myeloma, GAGE12C is overexpressed in patient groups with poor prognostic outcomes, indicating its potential role in disease progression and as a marker for high-risk patients (Moreaux2010A). 

In cervical cancer, the GAGE family, including GAGE12, is involved in conferring resistance to radiation-induced cell death. This resistance is achieved by enhancing chromatin dynamics, which facilitates efficient DNA repair and protects cells from apoptosis (Nin2023Biology). The anti-apoptotic properties of GAGE12C are further demonstrated in HeLa cells, where its overexpression leads to resistance against apoptosis induced by interferon-gamma or the death receptor Fas/CD95/APO-1 (Nin2023Biology).

GAGE12C is also linked to cancer metastasis, particularly in gastric cancer, where it is hypothesized to regulate epithelial-to-mesenchymal transition (EMT) genes. Knockdown of GAGE12C results in the downregulation of several EMT genes, suggesting its role in promoting metastasis (Nin2023Biology). These findings highlight the clinical significance of GAGE12C in cancer progression and resistance, making it a potential target for therapeutic interventions.


## References


[1. (Nin2023Biology) Dawn Sijin Nin and Lih-Wen Deng. Biology of cancer-testis antigens and their therapeutic implications in cancer. Cells, 12(6):926, March 2023. URL: http://dx.doi.org/10.3390/cells12060926, doi:10.3390/cells12060926. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells12060926)

[2. (Moreaux2010A) J. Moreaux, B. Klein, R. Bataille, G. Descamps, S. Maiga, D. Hose, H. Goldschmidt, A. Jauch, T. Reme, M. Jourdan, M. Amiot, and C. Pellat-Deceunynck. A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines. Haematologica, 96(4):574â€“582, December 2010. URL: http://dx.doi.org/10.3324/haematol.2010.033456, doi:10.3324/haematol.2010.033456. This article has 127 citations.](https://doi.org/10.3324/haematol.2010.033456)